UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 102

Sortiert nach

Levonorgestrel‐impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial

BJOG : an international journal of obstetrics and gynaecology, 2014-03, Vol.121 (4), p.477-486

2014

Volltextzugriff (PDF)

Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel‐impregnated intrauterine system or oral progestogens

BJOG : an international journal of obstetrics and gynaecology, 2016-08, Vol.123 (9), p.1512-1519

2016

Volltextzugriff (PDF)

Significance of progesterone receptors (PR‐A and PR‐B) expression as predictors for relapse after successful therapy of endometrial hyperplasia: a retrospective cohort study

BJOG : an international journal of obstetrics and gynaecology, 2019-06, Vol.126 (7), p.936-943

2019

Volltextzugriff (PDF)

Relapse Risk of Endometrial Hyperplasia After Treatment With the Levonorgestrel-Impregnated Intrauterine System or Oral Progestogens

Obstetrical & gynecological survey, 2016-08, Vol.71 (8), p.465-466

2016

Volltextzugriff (PDF)

Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone

Gynecologic oncology, 2003-12, Vol.91 (3), p.526-533

2003

Volltextzugriff (PDF)

Prognostic Markers for Detection of Coexistent Carcinoma in High-risk Endometrial Hyperplasia

Anticancer research, 2010-11, Vol.30 (11), p.4649-4655

2010

Volltextzugriff (PDF)

Computerised morphometrical analysis in endometrial hyperplasia for the prediction of cancer development. A long term retrospective study from northern Norway

Journal of clinical pathology, 2000-09, Vol.53 (9), p.697-703

2000

Volltextzugriff (PDF)

Loss of Expression of MLH1, MSH2, MSH6, and PTEN Related to Endometrial Cancer in 68 Patients With Endometrial Hyperplasia

International journal of gynecological pathology, 2003-04, Vol.22 (2), p.141-148

2003

Volltextzugriff (PDF)

Resection margins in conization as prognostic marker for relapse in high-grade dysplasia of the uterine cervix in northern Norway: a retrospective long-term follow-up material

Gynecologic oncology, 2004-05, Vol.93 (2), p.479-483

2004

Volltextzugriff (PDF)

Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone

Gynecologic oncology, 2005-06, Vol.97 (3), p.740-750

2005

Volltextzugriff (PDF)

Export of guanosine 3′,5′-cyclic monophosphate (cGMP) from human erythrocytes characterized by inside-out membrane vesicles

Scandinavian journal of clinical and laboratory investigation, 1996, Vol.56 (4), p.289-293

1996

Volltextzugriff (PDF)

Genetic derangements in the tumor suppressor gene PTEN in endometrial precancers as prognostic markers for cancer development: a population-based study from northern Norway with long-term follow-up

Gynecologic oncology, 2004-10, Vol.95 (1), p.82-88

2004

Volltextzugriff (PDF)

The molecular genetics and morphometry‐based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system

Cancer, 2005-06, Vol.103 (11), p.2304-2312

2005

Volltextzugriff (PDF)

Computerised morphometric study of the paraurethral tissue in young and elderly women

Neurourology and urodynamics, 2002, Vol.21 (6), p.529-533

2002

Volltextzugriff (PDF)

A Semiautomated Test for Microsatellite Instability and its Significance for the Prognosis of Sporadic Endometrial Cancer in Northern Norway

International journal of gynecological pathology, 2002-01, Vol.21 (1), p.27-33

2002

Volltextzugriff (PDF)

Cell Density Dependence of cAMP and cGMP Levels in Four Human Cell Lines Derived from Carcinomas of the Uterine Cervix

Gynecologic oncology, 1994-03, Vol.52 (3), p.320-325

1994

Volltextzugriff (PDF)

Topographic criteria in the diagnosis of tumor emboli in intramammary lymphatics

Cancer, 1990-09, Vol.66 (5), p.972-977

1990

Volltextzugriff (PDF)

Endometrial cancer, vasculitis of the genital tract and occult temporal arteritis

Histopathology, 2001-02, Vol.38 (2), p.178-179

2001

Volltextzugriff (PDF)

Urinary levels of cyclic guanosine monophosphate (cGMP) in patients with cancer of the uterine cervix: a valuable prognostic factor of clinical outcome?

European journal of cancer (1990), 1998-08, Vol.34 (9), p.1460-1462

1998

Volltextzugriff (PDF)

Significance of morphometric, DNA cytometric features, and other prognostic markers on survival of endometrial cancer patients in northern Norway

International journal of gynecological cancer, 2002-01, Vol.12 (1), p.49-56

2002

Volltextzugriff (PDF)

Effect of probenecid, verapamil and progesterone on the concentration-dependent and temperature-sensitive human erythrocyte uptake and export of guanosine 3′,5′ cyclic monophosphate (cGMP)

Scandinavian journal of clinical and laboratory investigation, 1995-12, Vol.55 (8), p.715-721

1995

Volltextzugriff (PDF)

α-Methyldopa For Climacteric Hot Flushes: A Double-Blind, Randomized, Cross-Over Study

Acta obstetricia et gynecologica Scandinavica, 1986, Vol.65 (5), p.405-409

1986

Volltextzugriff (PDF)

Significance of morphometric, DNA cytometric features, and other prognostic markers on survival of endometrial cancer patients in northern Norway

International journal of gynecological cancer, 2002-01, Vol.12 (1), p.49-56

2002

Volltextzugriff (PDF)

Non-genomic effects of progestins—inhibition of cell growth and increased intracellular levels of cyclic nucleotides

The Journal of steroid biochemistry and molecular biology, 2003, Vol.84 (1), p.1-8

2003

Volltextzugriff (PDF)

Effect of serum and cell density on transmembrane distribution of cAMP and cGMP in transformed (C4‐i) and non‐transformed (WI‐38) human cells

International journal of cancer, 1993-12, Vol.55 (6), p.957-962

1993

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(93)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Humans
(63)
Life Sciences & Biomedicine
(63)
Female
(55)
Middle Aged
(36)
Biological And Medical Sciences
(32)
Adult
(28)
Medical Sciences
(28)
Oncology
(28)
Aged
(25)
Tumors
(20)
Gynecology. Andrology. Obstetrics
(17)
Endometrial Hyperplasia
(15)
Female Genital Diseases
(15)
Obstetrics & Gynecology
(14)
Prognosis
(14)
Endometrial Neoplasms - Pathology
(12)
Male
(12)
Endometrial Hyperplasia - Drug Therapy
(11)
Follow-Up Studies
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Levonorgestrel‐impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial

Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel‐impregnated intrauterine system or oral progestogens

Significance of progesterone receptors (PR‐A and PR‐B) expression as predictors for relapse after successful therapy of endometrial hyperplasia: a retrospective cohort study

Relapse Risk of Endometrial Hyperplasia After Treatment With the Levonorgestrel-Impregnated Intrauterine System or Oral Progestogens

Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone

Prognostic Markers for Detection of Coexistent Carcinoma in High-risk Endometrial Hyperplasia

Computerised morphometrical analysis in endometrial hyperplasia for the prediction of cancer development. A long term retrospective study from northern Norway

Loss of Expression of MLH1, MSH2, MSH6, and PTEN Related to Endometrial Cancer in 68 Patients With Endometrial Hyperplasia

Resection margins in conization as prognostic marker for relapse in high-grade dysplasia of the uterine cervix in northern Norway: a retrospective long-term follow-up material

Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone

Export of guanosine 3′,5′-cyclic monophosphate (cGMP) from human erythrocytes characterized by inside-out membrane vesicles

Genetic derangements in the tumor suppressor gene PTEN in endometrial precancers as prognostic markers for cancer development: a population-based study from northern Norway with long-term follow-up

The molecular genetics and morphometry‐based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system

Computerised morphometric study of the paraurethral tissue in young and elderly women

A Semiautomated Test for Microsatellite Instability and its Significance for the Prognosis of Sporadic Endometrial Cancer in Northern Norway

Cell Density Dependence of cAMP and cGMP Levels in Four Human Cell Lines Derived from Carcinomas of the Uterine Cervix

Topographic criteria in the diagnosis of tumor emboli in intramammary lymphatics

Endometrial cancer, vasculitis of the genital tract and occult temporal arteritis

Urinary levels of cyclic guanosine monophosphate (cGMP) in patients with cancer of the uterine cervix: a valuable prognostic factor of clinical outcome?

Significance of morphometric, DNA cytometric features, and other prognostic markers on survival of endometrial cancer patients in northern Norway

Effect of probenecid, verapamil and progesterone on the concentration-dependent and temperature-sensitive human erythrocyte uptake and export of guanosine 3′,5′ cyclic monophosphate (cGMP)

α-Methyldopa For Climacteric Hot Flushes: A Double-Blind, Randomized, Cross-Over Study

Significance of morphometric, DNA cytometric features, and other prognostic markers on survival of endometrial cancer patients in northern Norway

Non-genomic effects of progestins—inhibition of cell growth and increased intracellular levels of cyclic nucleotides

Effect of serum and cell density on transmembrane distribution of cAMP and cGMP in transformed (C4‐i) and non‐transformed (WI‐38) human cells

Suchergebnisse filtern